ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q1SCImago #4,804Hybrid

Prostate

Abbreviation (ISO):PROSTATE
•
Identifier (ISSN):0270-4137(Print)/1097-0045(Online)
•
Publisher:Wiley-Liss Inc.
Clarivate IF (2026)
2.7↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Prostate

WoS Q3
13463.3520182.8820193.2820204.120214.0120222.820232.620242.520252.72026
Annual Impact Factor Metric
Current (2026):2.7
Scopus SJR & RankScopus Q1
1.014
#4,804

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
141

141 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
170articles/year
31.81% Gold OA•88.05% Original Research

Aims & Scope

The Prostate is a peer-reviewed journal dedicated to original studies of this organ and the male accessory glands. It serves as an international medium for these studies, presenting comprehensive coverage of clinical, anatomic, embryologic, physiologic, endocrinologic, and biochemical studies.

Topics Covered (Recognized by AI)
Medicine99.6%Biology86.5%Internal medicine86.1%Genetics85.9%Cancer81.8%Prostate72.8%Prostate cancer70.4%Chemistry62.8%Biochemistry61.7%Pathology48%Endocrinology41.7%Cancer research38%Gene30%Immunology24.3%Oncology21.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank120/198
IndexSCIE
JCRSCIE2026

UROLOGY & NEPHROLOGY

Q2
Rank50/134
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q2
Rank82/198
IndexSCIE
JCISCIE2026

UROLOGY & NEPHROLOGY

Q2
Rank47/134
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.7
Articles / Year153
Total Citations31
2025
IF2.5
Articles / Year218
Total Citations329
2024
IF2.6
Articles / Year199
Total Citations959
2023
IF2.8
Articles / Year199
Total Citations1,276
2022
IF4.012
Articles / Year202
Total Citations2,026

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,804Scopus Q1SCImago Profile
Scopus Coverage:1980-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.014

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.73

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,352 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,422
3-Year Documents494
Citable Documents474

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate24.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

UrologyQ1
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ANDROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Prostate (abbr: PROSTATE, ISSN: 0270-4137) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Liss Inc. in United States since 1980. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 1.014 (Q1), an H-index of 141.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 170 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,352 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Liss Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1980
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6d2f79db-b2af-4c0c-9201-a70a8aa86d8e
Database Updated: 2026-10-01